SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,100,264 | -21.6% | 8,491 | -33.1% | 0.23% | -25.2% |
| Q3 2022 | $1,403,000 | +47.4% | 12,689 | +45.5% | 0.30% | +17.8% |
| Q4 2018 | $952,000 | -60.1% | 8,722 | -40.9% | 0.26% | -26.8% |
| Q3 2018 | $2,385,000 | -29.8% | 14,766 | -42.5% | 0.35% | -33.8% |
| Q2 2018 | $3,396,000 | +14.7% | 25,692 | -35.7% | 0.54% | +8.5% |
| Q1 2018 | $2,962,000 | +6.6% | 39,980 | -19.9% | 0.49% | -1.0% |
| Q4 2017 | $2,778,000 | +0.1% | 49,920 | -18.4% | 0.50% | +35.0% |
| Q3 2017 | $2,774,000 | -21.0% | 61,155 | +6.9% | 0.37% | -21.8% |
| Q3 2016 | $3,512,000 | – | 57,186 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |